Management of false passages in patients practising clean intermittent self catheterisation.
OBJECTIVE
Clean intermittent self catheterisation (CISC) is commonly used by patients with impaired bladder emptying. But how to manage acute false passages in patients on CISC?


METHODS
Six patients experienced difficulty when performing intermittent catheterisation. Urethrocystoscopy demonstrated a new false passage in all of them. Treatment consisted of urethral stenting with an 14-16F indwelling catheter during 3-6 weeks and antibiotic therapy for 5 days.


RESULTS
The false passage disappeared on cystoscopy. During a mean follow up of 10 months (1-28 months), none of these patients developed another false passage. All are practising CISC without any further difficulty.


CONCLUSIONS
Analysis of our data suggests that temporary urethral stenting and antibiotic therapy are an excellent management in patients on CISC who develop an acute false passage.
Michielsen
D P
DP
Department of Urology, University of Antwerp, Edegem, Belgium.
Wyndaele
J J
JJ
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002404:Catheterization / Q000009:adverse effects* / Q000379:methods*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D012648:Self Care / Q000009:adverse effects* / Q000379:methods; D013119:Spinal Cord Injuries / Q000150:complications; D015607:Stents; D016896:Treatment Outcome; D014521:Urethra / Q000293:injuries*; D014522:Urethral Diseases / Q000209:etiology / Q000628:therapy*; D001750:Urinary Bladder, Neurogenic / Q000209:etiology / Q000534:rehabilitation*; D013520:Urologic Surgical Procedures / Q000379:methods; D014950:Wounds, Penetrating / Q000209:etiology / Q000628:therapy*
D000900:Anti-Bacterial Agents